Simple chromatographic and spectrophotometric determination of sofosbuvir in pure and tablet forms
Sherif Abdel-Naby Abdel-Gawad (1,*)
(1) Pharmaceutical Chemistry Department, Collage of Pharmacy, Prince Sattam Bin-Abdul Aziz University, Al-Kharj, 119924, Kingdom of Saudi Arabia
(*) Corresponding Author
Received: 14 Apr 2016, Accepted: 07 May 2016, Published: 30 Sep 2016
Two methods, a reversed phase high-performance liquid chromatographic (RP-HPLC) method and a direct ultra-violet spectrophotometric method, were adopted and validated for the quantification of sofosbuvir, which is a new antiviral agent used for treatment of patients with hepatitis C virus (HCV). Validation parameters such as linearity, accuracy, precision, specificity, limits of detection and quantification were determined according to the guidelines of International Conference on Harmonization (ICH)-Q2B. The RP-HPLC method was applied on HypersilTM ODS C18 column (150×4.6 mm, 5 µm) as a stationary phase. The mobile phase was optimized according to the polarity of the studied drug. It was methanol: acetonitrile (90:10, v:v), pumped using an isocratic mode with flow rate of 1 mL/min and UV detection at 260 nm. The UV spectrophotometric method was performed for the studied drug at 260 nm. The calibration curves were linear in the ranges of 2-60 µg/mL and 5-40 µg/mL for the RP-HPLC and UV spectrophotometric methods, respectively. The proposed methods are accurate, sensitive and precise, so they can be successfully adopted for the reliable determination of sofosbuvir content in its tablet form.
This Abstract was viewed 899 times | PDF Article downloaded 294 times
. Dalia W. Zidan, Wafaa S. Hassan, Manal S. ElMasry, Abdalla A. Shalaby
Novel spectrophotometric and factor-based multivariate calibration-prediction techniques for determination of two inhibitors of hepatitis C-virus and hepatocellular carcinoma in pure, human urine, and human plasma
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 213, 288, 2019
. Rania M. El-Gamal, Sherif A. Abdel-Gawad, Fathalla F. Belal, Moustapha E. Moustapha
Selective and sensitive spectrofluorimetric quantification of velpatasvir in presence of sofosbuvir. Application to their co-formulated tablet
RSC Advances 8(57), 32909, 2018
. Sherif Abdel-Naby Abdel-Gawad
Validated simultaneous spectrophotometric quantification of a new antiviral combination
European Journal of Chemistry 8(1), 8, 2017
. Aya A Youssef, N Magdy, Lobna A Hussein, A M El-Kosasy
Validated RP-HPLC Method for Simultaneous Determination of Ribavirin, Sofosbuvir and Daclatasvir in Human Plasma: A Treatment Protocol Administered to HCV Patients in Egypt
Journal of Chromatographic Science 57(7), 636, 2019
. Roshdy E. Saraya, Magda Elhenawee, Hanaa Saleh
Development of a highly sensitive high-performance thin-layer chromatography method for the screening and simultaneous determination of sofosbuvir, daclatasvir, and ledipasvir in their pure forms and their different pharmaceutical formulations
Journal of Separation Science 41(18), 3553, 2018
. Moustapha Eid Moustapha, Rania Mohamed El-Gamal, Fathalla Fathalla Belal
Two novel UPLC methods utilizing two different analytical columns and different detection approaches for the simultaneous analysis of velpatasvir and sofosbuvir: application to their co-formulated tablet
BMC Chemistry 13(1), , 2019
. Maha Osama El-Kayal, Maha Nasr Sayed, Nahed Dawood Mortada, Seham Elkheshen
Development and validation of a simple and rapid UPLC method for the in-vitro estimation of (-)-epigallocatechin-3-gallate in lipid-based formulations
European Journal of Chemistry 9(1), 7, 2018
. Mansuri Reema, Patel Dhara, Patel Khushboo, Meshram Dhananjay
In depth investigation of quantitative analytical and bioanalytical techniques of hepatitic drug sofosbuvir in different matrices: a review
Journal of Analytical & Pharmaceutical Research 7(2), , 2018
. Asselah, T. Expert. Opin. Pharmacother. 2014, 15, 121-130.
. Herbst, J. D. A.; Reddy, K. R. Expert. Opin. Investig. Drugs 2013, 22, 527-536.
. Gane, E. J.; Stedman, C. A.; Hyland, R. H.; Ding, X.; Svarovskaia, E.; Symonds, W. T.; Hindes, R. G.; Berrey, M. M. N. Engl. J. Med. 2013, 368, 34-44.
. http://www.who.int/selection_medicines/committees/expert/20/applications/LedipasvirFDC.pdf, accessed 10 April 2016.
. Shi, X.; Zhu, D.; Lou, J.; Zhu, B.; Hu, A. R.; Gan, D. J. Chromatogr. B 2015, 1002, 353-357.
. Pan, C.; Chen, Y.; Chen, W.; Zhou, G.; Jin, L.; Zheng, Y.; Lin, W.; Pan, Z. J. Chromatogr. B 2016, 1008, 255-259.
. Rezk, M. R.; Basalious, E. B.; Karim, I. A. J. Pharm. Biomed. Anal. 2015, 117, 97-104.
. ICH Topic Q2 (R1) validation of Analytical Procedures: Text and methodology, note for guidance on validation of analytical procedures text and methodology (CPMP/ICH/381/95), June 1995.
. Varma, M. V. S.; Kapoor, N.; Sarkar, M.; Panchagnula, R. J. Chromatogr. B 2004, 813, 347-352.
. Sarkar, M.; Khandavilli, S.; Panchagnula, R. J. Chromatogr. B 2006, 830, 349-354.
How to cite
DOI Link: https://doi.org/10.5155/eurjchem.7.3.375-379.1439
- There are currently no refbacks.
© Copyright 2019 • Atlanta Publishing House LLC • All Right Reserved.
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2019 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 4614 Lavista road, Tucker, GA, 30084, USA. Registered in USA.